Dr. Amin is the Managing Partner of Madryn Asset Management, LP. Prior to forming Madryn, Dr. Amin was a Partner at Visium Fund Management, LP, where he was the head of the fund’s New York office and was responsible for structured debt, growth equity, and royalty investments in the healthcare industry, from 2014 through 2017.

Prior to joining Visium, Dr. Amin was a Managing Director at Siguler Guff & Company, LP, a multi-strategy private equity firm, from 2009 through 2014. At Siguler Guff, Dr. Amin headed the firm’s healthcare investment strategy and was responsible for sourcing and leading healthcare investments including royalty monetizations, specialty financings, and buyout/growth equity transactions in both developed and emerging economies. Prior to Siguler Guff, Dr. Amin headed the private equity advisory business of Summit Strategies Group.

Dr. Amin obtained an MD from Washington University in St. Louis, Missouri where he completed his residency and practiced as a physician before joining biopharmaceutical company Novactyl, Inc. as Chief Clinical Officer. In addition to an MD, Dr. Amin received an MHA and a BA in classics from Washington University in St. Louis. Dr. Amin is board certified in Internal Medicine.